查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029年全球肝病治療市場規模研究與預測，按治療類型、疾病類型（肝炎、自身免疫性疾病、非酒精性脂肪肝、癌症、遺傳性疾病、其他）及區域分析
市場調查報告書
商品編碼
1279069

2022-2029年全球肝病治療市場規模研究與預測，按治療類型、疾病類型（肝炎、自身免疫性疾病、非酒精性脂肪肝、癌症、遺傳性疾病、其他）及區域分析

Global Liver Disease Treatment Market Size study & Forecast, by Treatment Type, by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease, Cancer, Genetic Disorders, Others) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

肝臟是一個重要的器官，唯一功能是處理和消除潛在的有害身體毒素。任何引起肝臟炎症並可能阻礙肝臟正常功能的疾病狀況都被稱為肝病。肝臟問題可由感染、自身免疫性疾病、過度使用非處方藥、受傷、飲酒和其他因素引起。免疫球蛋白也用來治療某些類型的肝炎。飲酒和不健康的生活方式是導致全球非酒精性脂肪肝（NAFLD）、肝硬化、肝炎和肝癌等肝臟疾病患病率上升的主要原因。此外，世界各地老年人口的增加也導致了疾病的功能障礙。因此，因遺傳性基因疾病和上述不同的肝病而入院的人數激增。此外，不良的飲食習慣和不健康的飲食習慣導致體重過重，進一步導致肥胖症。導致成人脂肪肝的兩個主要因素是肥胖和酗酒。由於超重或肥胖，肝臟中出現脂肪。這導致了持續的炎症和肝臟疤痕（也稱為肝硬化）。肥胖和非酒精性脂肪肝是密切相關的。過多的脂肪會導致胰島素抵抗和炎症信號。高血壓、高膽固醇、體重過重、糖尿病或胰島素抵抗的患者更容易患脂肪肝。

此外，由於免疫水準比成年人低，老年群體更容易患肝病。此外，老齡化已被證明會增加對急性肝損傷的脆弱性。因此，在預測期內，老齡人口的增加預計將支持市場成長。根據世界銀行的數據，2015年世界上65歲及以上人口總數的8%，2021年該比例達到10%。此外，為開發更好的肝病治療方法而進行的研發活動投資不斷增加，預計將在預測期內為市場創造一個有利可圖的機會。然而，與肝病治療藥物和疫苗有關的嚴格的監管審批，在2022-2029年的預測期內抑制了市場成長。

全球肝病治療市場研究的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。北美是全球市場佔有率的主導地區，這是因為該地區有主要的參與者，酒精消費的增加，不健康的生活方式導致肥胖和體重增加，以及醫療支出的增加。同時，由於研發活動的增加、肝臟疾病的激增、未得到滿足的醫療需求以及醫療部門投資的成長等因素，預計亞太地區將在預測期內表現出最高的成長率，這將為整個亞太地區的肝病治療市場創造有利的成長前景。

該研究的目的是確定近年來不同領域和國家的市場規模，並對未來幾年的價值進行預測。本報告旨在將研究涉及的國家內的產業的品質和數量方面都涵蓋其中。

本報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來成長。此外，它還涵蓋了微觀市場的潛在機會，供利益相關者投資，並詳細分析了競爭格局和主要參與者的產品。

目錄

第一章：執行摘要

  • 市場簡介
  • 2019-2029年全球和細分市場的估計和預測
    • 2019-2029年，肝病治療市場，按地區分類
    • 2019-2029年肝病治療市場，按治療類型分類
    • 2019-2029年肝病治療市場，按疾病類型分類
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章：全球肝病治療市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 研究的範圍
    • 產業演變
  • 研究考慮的年份
  • 貨幣兌換率

第三章：全球肝病治療市場動態

  • 肝病治療市場影響分析（2019-2029年）
    • 市場驅動因素
      • 肝臟疾病的發病率不斷上升
      • 飲酒和不良飲食習慣的上升
      • 老年人口激增
    • 市場挑戰
      • 與肝病治療藥物和疫苗有關的嚴格的監管審批
    • 市場機會
      • 研發投資不斷增加

第四章：全球肝病治療市場產業分析

  • 波特五力模型
    • 供應商的討價還價能力
    • 買方的討價還價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力模型的未來方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 經濟
    • 社會
    • 技術
  • 最佳投資機會
  • 最佳策略
  • 產業專家展望
  • 分析師建議和結論

第五章：風險評估：COVID-19的影響

  • 評估COVID-19對產業的整體影響
  • COVID-19前和COVID-19後的市場情況

第六章：全球肝病治療市場，按治療類型分類

  • 市場簡介
  • 全球肝病治療市場，按治療類型，性能-潛力分析
  • 2019-2029年全球肝病治療市場按治療類型的估計和預測
  • 肝病治療市場，分項分析
    • 抗病毒藥物
    • 免疫抑製劑
    • 疫苗
    • 免疫球蛋白類藥物
    • 皮質類固醇
    • 靶向治療
    • 化療

第7章：全球肝病治療市場，按疾病類型

  • 市場簡介
  • 按疾病類型分類的全球肝病治療市場，性能-潛力分析
  • 2019-2029年全球肝病治療市場按疾病類型的估計和預測
  • 肝病治療市場，細項分析
    • 肝炎
    • 自身免疫性疾病
    • 非酒精性脂肪肝(NAFLD)
    • 癌症
    • 遺傳性疾病
    • 其他

第八章：全球肝病治療市場，區域分析

  • 肝病治療市場，區域市場簡介
  • 北美洲
    • 美國。
      • 2019-2029年治療類型細分估計和預測
      • 疾病類型細分估計和預測，2019-2029年
    • 加拿大
  • 歐洲肝病治療市場簡介
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 歐洲其他地區
  • 亞太地區肝病治療市場簡述
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉美肝病治療市場概況
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 世界其他地區

第九章：競爭情報

  • 頂級市場戰略
  • 公司簡介
    • Abbvie Inc.
      • 關鍵資訊
      • 概況
      • 財務（取決於數據的可用性）
      • 產品摘要
      • 近期發展情況
    • Abbott Laboratories
    • Astellas Pharma Inc.
    • Bristol-Myers Squibb
    • Eli Lilly And Company
    • Emergent Biosolutions Inc. (Cangene Biopharma)
    • F. Hoffmann-La Roche Ag
    • Gilead Sciences, Inc.
    • Merck & Co. Inc.
    • Viatris Inc.

第十章：研究過程

  • 研究過程
    • 資料探勘
    • 數據分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Liver Disease Treatment Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The liver is a crucial organ whose sole function is to process and eliminate potentially harmful body toxins. Any disease condition that causes liver inflammation and may impede the liver's normal function is referred to as liver disease. Liver problems can be caused by infections, autoimmune disorders, using over-the-counter medications excessively, getting injured, drinking alcohol, and other factors. Immunoglobulin is also used to treat certain types of hepatitis. Alcohol consumption and an unhealthy lifestyle are the main causes of the rising prevalence of liver disorders such as non-alcoholic fatty liver disease (NAFLD), liver cirrhosis, hepatitis, and liver cancer worldwide. Additionally, an increase in elderly population around the world contributes to disease dysfunction. As a result, there has been an upsurge in hospital admissions for both hereditary genetic disorders and the different liver diseases indicated above. In addition, poor eating habits and unhealthy diet causes excess weight further leading to obesity. The two main factors contributing to fatty liver disease in adults are obesity and alcoholism. As a result of being overweight or obese, fat develops in the liver. This results in persistent inflammation and liver scarring (also known as cirrhosis). Obesity and non-alcoholic fatty liver disease are closely related. Excess fat leads to insulin resistance and inflammatory signals. Patients with high blood pressure, high cholesterol, excess body weight, diabetes, or insulin resistance are more susceptible to developing fatty liver disease.

Furthermore, owing to low immunity levels than adults, the geriatric population is more prone to liver illnesses. In addition, ageing has been shown to increase vulnerability to acute liver injury. Thus, the rising aging population is anticipated to support market growth during the forecast period. According to the World Bank, 8% of the total population aged 65 and older lived in the world in 2015, and in 2021 the rate reached 10 %. Additionally, the rising investments in R&D activities for the development of better liver disease treatment are anticipated to create a lucrative opportunity for the market during forecast period. However, the stringent regulatory approvals related to liver disease treatment drugs and vaccines stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Liver Disease Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key players, rise in consumption of alcohol, unhealthy lifestyle leading to obesity & weight gain, and rise in healthcare expenditure in the region. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as increase in R&D activities, surge in liver diseases, unmet medical demands, and growing investments in the healthcare sector which would create lucrative growth prospects for the Liver Disease Treatment market across Asia Pacific region.

Major market players included in this report are:

  • Abbvie Inc.
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Bristol-Myers Squibb
  • Eli Lilly And Company
  • Emergent Biosolutions Inc. (Cangene Biopharma)
  • F. Hoffmann-La Roche Ag
  • Gilead Sciences, Inc.
  • Merck & Co. Inc.
  • Viatris Inc.

Recent Developments in the Market:

  • April 2020, Alnylam Pharmaceuticals Inc. and Dicerna Pharmaceuticals Inc. collaborated to create and market investigational RNAi therapies for the treatment of liver disease caused by alpha-1 antitrypsin deficiency.

Global Liver Disease Treatment Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Treatment Type, Disease Type, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Treatment Type:

  • Antiviral Drugs
  • Immunosuppressants
  • Vaccines
  • Immunoglobulins
  • Corticosteroids
  • Targeted Therapy
  • Chemotherapy

By Disease Type:

  • Hepatitis
  • Autoimmune Diseases
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Cancer
  • Genetic Disorders
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Liver Disease Treatment Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Liver Disease Treatment Market, by Treatment Type, 2019-2029 (USD Billion)
    • 1.2.3. Liver Disease Treatment Market, by Disease Type, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Liver Disease Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Liver Disease Treatment Market Dynamics

  • 3.1. Liver Disease Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing incidence of liver diseases
      • 3.1.1.2. Rising alcohol consumption and poor dietary habits
      • 3.1.1.3. Surge in geriatric population
    • 3.1.2. Market Challenges
      • 3.1.2.1. Stringent regulatory approvals related to liver disease treatment drugs and vaccines
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising Investment in R&D

Chapter 4. Global Liver Disease Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Liver Disease Treatment Market, by Treatment Type

  • 6.1. Market Snapshot
  • 6.2. Global Liver Disease Treatment Market by Treatment Type, Performance - Potential Analysis
  • 6.3. Global Liver Disease Treatment Market Estimates & Forecasts by Treatment Type 2019-2029 (USD Billion)
  • 6.4. Liver Disease Treatment Market, Sub Segment Analysis
    • 6.4.1. Antiviral Drugs
    • 6.4.2. Immunosuppressants
    • 6.4.3. Vaccines
    • 6.4.4. Immunoglobulins
    • 6.4.5. Corticosteroids
    • 6.4.6. Targeted Therapy
    • 6.4.7. Chemotherapy

Chapter 7. Global Liver Disease Treatment Market, by Disease Type

  • 7.1. Market Snapshot
  • 7.2. Global Liver Disease Treatment Market by Disease Type, Performance - Potential Analysis
  • 7.3. Global Liver Disease Treatment Market Estimates & Forecasts by Disease Type 2019-2029 (USD Billion)
  • 7.4. Liver Disease Treatment Market, Sub Segment Analysis
    • 7.4.1. Hepatitis
    • 7.4.2. Autoimmune Diseases
    • 7.4.3. Non-alcoholic Fatty Liver Disease (NAFLD)
    • 7.4.4. Cancer
    • 7.4.5. Genetic Disorders
    • 7.4.6. Others

Chapter 8. Global Liver Disease Treatment Market, Regional Analysis

  • 8.1. Liver Disease Treatment Market, Regional Market Snapshot
  • 8.2. North America Liver Disease Treatment Market
    • 8.2.1. U.S. Liver Disease Treatment Market
      • 8.2.1.1. Treatment Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Disease Type breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Liver Disease Treatment Market
  • 8.3. Europe Liver Disease Treatment Market Snapshot
    • 8.3.1. U.K. Liver Disease Treatment Market
    • 8.3.2. Germany Liver Disease Treatment Market
    • 8.3.3. France Liver Disease Treatment Market
    • 8.3.4. Spain Liver Disease Treatment Market
    • 8.3.5. Italy Liver Disease Treatment Market
    • 8.3.6. Rest of Europe Liver Disease Treatment Market
  • 8.4. Asia-Pacific Liver Disease Treatment Market Snapshot
    • 8.4.1. China Liver Disease Treatment Market
    • 8.4.2. India Liver Disease Treatment Market
    • 8.4.3. Japan Liver Disease Treatment Market
    • 8.4.4. Australia Liver Disease Treatment Market
    • 8.4.5. South Korea Liver Disease Treatment Market
    • 8.4.6. Rest of Asia Pacific Liver Disease Treatment Market
  • 8.5. Latin America Liver Disease Treatment Market Snapshot
    • 8.5.1. Brazil Liver Disease Treatment Market
    • 8.5.2. Mexico Liver Disease Treatment Market
    • 8.5.3. Rest of Latin America Liver Disease Treatment Market
  • 8.6. Rest of The World Liver Disease Treatment Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Abbvie Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Abbott Laboratories
    • 9.2.3. Astellas Pharma Inc.
    • 9.2.4. Bristol-Myers Squibb
    • 9.2.5. Eli Lilly And Company
    • 9.2.6. Emergent Biosolutions Inc. (Cangene Biopharma)
    • 9.2.7. F. Hoffmann-La Roche Ag
    • 9.2.8. Gilead Sciences, Inc.
    • 9.2.9. Merck & Co. Inc.
    • 9.2.10. Viatris Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Liver Disease Treatment Market, report scope
  • TABLE 2. Global Liver Disease Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Liver Disease Treatment Market estimates & forecasts by Treatment Type 2019-2029 (USD Billion)
  • TABLE 4. Global Liver Disease Treatment Market estimates & forecasts by Disease Type 2019-2029 (USD Billion)
  • TABLE 5. Global Liver Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Liver Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Liver Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Liver Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Liver Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Liver Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Liver Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Liver Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Liver Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Liver Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Liver Disease Treatment Market
  • TABLE 70. List of primary sources, used in the study of global Liver Disease Treatment Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Liver Disease Treatment Market, research methodology
  • FIG 2. Global Liver Disease Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Liver Disease Treatment Market, key trends 2021
  • FIG 5. Global Liver Disease Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Liver Disease Treatment Market, porters 5 force model
  • FIG 7. Global Liver Disease Treatment Market, pest analysis
  • FIG 8. Global Liver Disease Treatment Market, value chain analysis
  • FIG 9. Global Liver Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Liver Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Liver Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Liver Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Liver Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Liver Disease Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Liver Disease Treatment Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Liver Disease Treatment Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Liver Disease Treatment Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Liver Disease Treatment Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Liver Disease Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable